PARADIGM SHIFT IN OVARIAN CANCER POINTS TO FALLOPIAN TUBE AS SITE OF ORIGIN
In an interview with Cancer Therapy Advisor, Dr. Ronny Drapkin, MD, PhD, the Franklin Payne Chair in Gynecologic Oncology and director of… View more
OVARIAN CANCERS: EVOLVING PARADIGMS IN RESEARCH AND CARE
The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine Committee on the State of the Science in Ovarian… View more
NANOTECHNOLOGY USES LIGHT TO SHOW DENSITY OF TUMORS
Tina’s Wish grant recipient, Daniel Heller, PhD, of Memorial Sloan Kettering Cancer Center discusses his use of nanotechnology to demonstrate tumor density.
LIU BRIEFS CONGRESS ON IMPORTANCE OF FEDERAL FUNDING
Dr. Joyce Liu of Dana-Farber Cancer Institute discusses the importance of federal funding after her successful clinical trial, which was funded by… View more
ARE WE CLOSER TO SCREENING AVERAGE-RISK WOMEN FOR OVARIAN CANCER?
Gynecologic oncologist Douglas Levine says that progress to find new ways to screen women at average risk for ovarian cancer is slow… View more
NOVEL CAUSE OF OVARIAN CANCER DRUG RESISTANCE IDENTIFIED
Dipanjan Chowdhury, PhD, and Panagiotis Konstantinopoulos, MD, PhD, identified a new resistance mechanism in which ovarian cancer cells turn off one of… View more